BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Prometheus Laboratories Inc. 

5739 Pacific Center Boulevard

San Diego  California  92121-4203  U.S.A.
Phone: 888-423-5227 Fax: 858-824-0896


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Prometheus Laboratories Inc. Release: PROCLAIM Patient Registry Data Show Extension Of Overall Survival Benefits Beyond Complete And Partial Responders In Metastatic Renal Cell Carcinoma Patients Treated With High-Dose Interleukin-2 (HD IL-2) 5/30/2014 9:02:01 AM
Prometheus Laboratories Inc. Announces Inclusion of Proleukin® (Aldesleukin for Injection) / Interleukin-2 in SITC Guidelines for Treatment of Cutaneous Melanoma 10/11/2013 8:40:01 AM
Prometheus Laboratories Inc. Appoints Chief Executive Officer 9/19/2013 7:18:13 AM
Prometheus Laboratories Inc. Launches PROCLIVITY 02, a Phase IV Multi-Center Study Comparing the Sequence of Proleukin® (Aldesleukin for Injection) and Yervoy® (Ipilimumab) in Patients With Metastatic Melanoma 5/30/2013 10:41:58 AM
Prometheus Laboratories Inc. Presents New Data On Growing IBD Diagnostic Portfolio at Digestive Disease Week 2013 5/23/2013 6:14:46 AM
Prometheus Laboratories Inc. Launches PROCLIVITY(SM) 01 Clinical Trial of Proleukin® (Aldesleukin for Injection) Plus Vemurafenib Therapy in Patients with Metastatic Melanoma 5/9/2013 11:37:13 AM
Prometheus Laboratories Inc. Release: New Data Support Use of PROMETHEUS® Anser™ IFX Assay in Managing Infliximab Treatment Failure Among Inflammatory Bowel Disease Patients 10/22/2012 10:28:35 AM
Prometheus Laboratories Inc. Launches New Monitoring Test to Help Guide Inflammatory Bowel Disease Management 8/1/2012 10:12:01 AM
Clinipace Inc. Selected to Manage Prometheus Laboratories Inc. Oncology Program 7/17/2012 9:56:45 AM
New Data Support Role of Prometheus Laboratories Inc.' Novel Assay in Optimizing IBD Treatment Management 5/23/2012 9:18:29 AM
12345678